The evidence continues to mount. The U.S. Food and Drug Administration (FDA) must urgently take action to protect women and unborn children against the chemical abortion drug, mifepristone.  Please take a moment to send a message to Acting FDA Commissioner Diamantas...

Last year, President Trump's "One Big Beautiful Bill Act" (H.R. 1) prevented Medicaid funding from going to major abortion providers for one year. This was a tremendous victory, but unfortunately, that provision is set to expire on July 4, 2026.  We should be...

On April 1, Bishop Daniel E. Thomas, chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities, endorsed the Safeguarding Women from Chemical Abortion Act (S. 4066/HR. 7902). This legislation has been introduced in the U.S. Congress by U.S...